Learn More
Isoniazid, G-Biosciences

Description
This prodrug is transformed by catalase-peroxidases, where its active form inhibits an enoyl-reductase (InhA). Inhibition of InhA compromises bacterial cell walls by preventing mycolic acid synthesis, disrupting fluid homeostasis and leading to cell death.
Specifications
Specifications
| Quantity | 100 g |
| Percent Purity | 95% |
| Grade | Laboratory |
| Physical Form | Powder |
| Product Line | Gibco |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.